Evidence map›Paper›PMID 41742231›Full record

ArticleJournal of cosmetic dermatology2026

Melanin Metabolism: A Novel Oxidative Degradation Mechanism and Regulation by Hydrolyzed Conchiolin Protein.

Xinyi Zhao, Haifeng Zeng, Long Zhu, Lihao Gu

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinyi ZhaoR&D Department, Osman Biological Co., Ltd., Deqing, China.
Haifeng ZengBeauty Hi-Tech Innovation Co., Ltd., Kobe, Japan.
Long ZhuR&D Department, Osman Biological Co., Ltd., Deqing, China.
Lihao GuR&D Department, Osman Biological Co., Ltd., Deqing, China.ORCID https://orcid.org/0009-0004-6638-4227

Funding

Osman Biological Co., Ltd.
6 · The paper itself

Abstract

backgroundMost pharmacological depigmenting agents and cosmetic skin-brightening products achieve their effects by suppressing melanogenesis. However, the fate of melanin after melanosome transfer to keratinocytes-and the mechanisms governing its intracellular clearance-remains insufficiently explored.

aimsThis study aimed to elucidate the intracellular mechanism of melanin degradation in keratinocytes and to establish a simplified and operable experimental strategy for evaluating melanin clearance beyond melanogenesis inhibition.

methodsA simplified in vitro model was established in which human epidermal keratinocytes phagocytosed isolated melanosomes, allowing investigation of melanin degradation independent of melanocyte activity. In parallel, a cell-free oxidative system consisting of ferrous ions and hydrogen peroxide was employed to chemically induce hydroxyl radical-mediated melanin degradation. Lysosomal activity, intracellular oxidative status, hydroxyl radical (•OH) generation, melanin content, and pH dependence were assessed using fluorescence imaging and biochemical assays.

resultsKeratinocytes exhibited a two-step melanin degradation process involving lysosomal proteolysis followed by oxidative breakdown mediated by •OH. Treatment with hydrolyzed conchiolin protein (HCP) enhanced melanin degradation by promoting lysosomal activation and modulating intracellular oxidative conditions. Fluorescence imaging demonstrated partial colocalization of •OH signals with lysosomes and suggested alterations in lysosomal pH following HCP exposure. Chemical assays further revealed that alkaline conditions more effectively promoted hydroxyl radical-mediated melanin degradation.

conclusionsThis study identifies an intracellular melanin degradation pathway operating within keratinocytes and presents a simplified experimental framework integrating cellular and cell-free models. HCP emerges as a modulator of lysosomal-oxidative pigment clearance, offering an alternative pigmentation control strategy beyond melanogenesis inhibition and supporting the development of skin-brightening approaches that preserve physiological pigment homeostasis.

Indexed as

hydrolyzed conchiolin protein (HCP)hydroxyl radicalsintracellular melanin degradationkeratinocyteslysosomal proteolysismelanin metabolismoxidative degradation

Identifiers

PMID41742231
PMCPMC12936266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.